Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis

• Ran Cui ,

  Contributed equally to this work with: Ran Cui, Yun Li

  Roles Conceptualization, Investigation, Methodology, Software, Validation, Visualization

  Affiliation Department of Oncology, The First People’s Hospital of Neijiang, Neijiang, Sichuan, China

  ⨯
• Yun Li ,

  Contributed equally to this work with: Ran Cui, Yun Li

  Roles Data curation, Writing – original draft

  Affiliation Department of Oncology, The First People’s Hospital of Neijiang, Neijiang, Sichuan, China

  ⨯
• Xinlin Yu,

  Roles Methodology, Supervision

  Affiliation Department of Oncology, The Second People’s Hospital of Neijiang, Neijiang, Sichuan, China

  ⨯
• Chun Wei,

  Roles Supervision

  Affiliation Department of Oncology, The Second People’s Hospital of Neijiang, Neijiang, Sichuan, China

  ⨯
• Ou Jiang

  Roles Writing – review & editing

  * E-mail: Jiangou628@163.com

  Affiliation Department of Oncology, The First People’s Hospital of Neijiang, Neijiang, Sichuan, China

  https://orcid.org/0000-0002-8391-4961

  ⨯